AbbVie increases 9.7% since earning reports: Can it persist? | World Pharma Today
AbbVie News Center - Press Kits
AbbVie Eyes Selling at Least $13 Billion of Bonds to Fund M&A - BNN Bloomberg
SY Investing on X: "$ABBV $AGN AbbVie announced that it has completed its acquisition of Allergan following receipt of regulatory approval from all government authorities required by the transaction agreement and approval
Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiation
Vitiligo Bordeaux : actualité
AbbVie News Center - Press Kits
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio – KXAN Austin
SEC Filing | AbbVie
Inventiva receives a €3.5 m milestone payment from AbbVie
AbbVie News Center - Press Kits
AbbVie's MAVIRET® (glecaprevir/pibrentasvir) accepted for use within NHS Scotland | AbbVie UK
AbbVie News Center - Fact Sheets
AbbVie News Center - Press Kits
AbbVie News Center - News
Caris Life Sciences on X: "#PressRelease - @ConcertAI and Caris Life Sciences announce multi-year partnership to support @abbvie's precision medicine-driven research and development efforts, and clinical trial optimization in oncology. Learn more:
Abbvie voluntarily recalls Ibrutinib in MCL and MZL
AbbVie - AbbVie Newsroom
AbbVie names Robert A. Michael as new CEO By Investing.com
AbbVie: A Post Allergan Powerhouse (NYSE:ABBV) | Seeking Alpha
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion | Reuters
AbbVie News Center - News
RINVOQ by AbbVie Set to Experience Tremendous Growth by 2032.
Press Release Format NESTLE | PDF | Digestion | Nutrition
PharmaState.academy on X: "#AbbVie Announces Leadership Team and Creation of New Business, #Allergan #Aesthetics, Upon Completion of #Acquisition Follow #PharmaState Page & get #Pharma Exclusive Updates! #BreakingNewsPharma #pharmanews #breakingnews ...
ABBV Infographic: AbbVie's Q1 2023 earnings and revenue decline | AlphaStreet
